Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02_AG strains of HIV-1 in Abidjan, Côte d'Ivoire

Journal of Clinical Virology

Volumn 32, Issue 1, 2005, Pages 60-66

  Bilé, Ebi C ^a   Adjé Touré, Christiane ^a   Borget, Marie Yolande ^a   Kalou, Mireille ^a   Diomande, Fabien ^a   Chorba, Terence ^d   Nkengasong, John N ^b,c  

^a Project RETRO CI Abidjan   (Côte d’Ivoire)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d HIV TB Prev Centers Dis C   (China)

Author keywords

Africa; HIV subtypes; Resistance assays

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COTE D'IVOIRE; GENE MUTATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; SAMPLE; VIRAL GENETICS; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS RESISTANCE; VIRUS STRAIN;

ANTI-HIV AGENTS; BIOLOGICAL ASSAY; COTE D'IVOIRE; DRUG RESISTANCE, MULTIPLE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MUTATION; REAGENT KITS, DIAGNOSTIC;

EID: 9644268116     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.07.008     Document Type: Article

References (12)

1. C. Adje, R. Cheingsong, T.H. Roels, C. Maurice, G. Djomand, and W. Verbiest High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire J. Acquir. Immune Defic. Syndr. 26 2001 501 506
2. S. Cuningham, B. Ank, D. Lewis, L. Wei, W. Michael, and J. Dileanis Performance of the Applied Biosystems ViroSeq HIV-1 Genotyping system for analysis of HIV-1 in pediatric plasma samples J. Clin. Microbiol. 39 4 2001 1254 1257
3. G. Djomand, T. Roels, T. Ellerbrock, D. Hanson, F. Diomande, and B. Monga Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire AIDS 17 Suppl. 3 2003 S5 S16
4. M. Erali, S. Page, L. Reimer, and R. Hillyard Human immunodeficiency virus Type 1 drug resistance testing: a comparison of three sequence-based methods J. Clin. Microbiol. 39 6 2001 2157 2165
5. R.M. Grant, D.R. Kuritzkes, V.A. Johnson, J.W. Mellors, J.L. Sullivan, and R. Swanstrom Accuracy of the TRUGENE HIV-1 Genotyping Kit J. Clin. Microbiol. 41 4 2003 1586 1593
6. K. Hertogs, M.P. de Béthune, and V. Miller A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs Antimicrob. Agents Chemother. 42 1998 269 276
7. M. Mracna, G. Becker-Pergola, J. Dileanis, L.A. Guay, S. Cunningham, and J.B. Jackson Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda J. Clin. Microbiol. 39 2001 4323 4327
8. J.N. Nkengasong, C. Maurice, S. Koblavi, M. Kalou, D. Yavo, and M. Maran Evaluation of HIV serial and a parallel serologic testing algorithm in Abidjan Cote d'Ivoire AIDS 13 1999 109 117
9. J.N. Nkengasong, C. Maurice, S. Koblavi, M. Kalou, C. Bile, and D. Yavo Field evaluation of a combination of monospecific ELISAs for type-specific diagnsosis of HIV-1 and HIV-2 infections in HIV-seropositive persons in Abidjan Ivory Coast J. Clin. Microbiol. 36 1998 123 127
10. Pauwels R, Hertogs K, Kemp S, et al. Comprehensive HIV drug resistance monitoring using rapid, high-throughput phenotypic and genotypic assays with correlative data analysis. In: Abstracts of the 2nd International Workshop on HIV Drug Resistance and Treatment Strategies; 1998 June 24-27; Lake Maggiore, Italy. [Abstract 51].
11. Stanford HIV RT and protease sequence database, 2000. Available at http://hivdbstanford.edu/hiv/notes.pl.
12. P.J. Weidle, S. Malamba, R. Mwebaze, C. Sozi, G. Rukundo, and R. Downing Assesment of a pilot antiretroviral drug therapy programme in Ouganda: patient's response, survival and drug resistance Lancet. 360 2002 34 40